Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

518800

	registered interest
	date	18/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prime Minister: Ministerial Policy Advisers
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what action they are taking to ensure that NICE guidance is followed in the use of faecal microbiota transplants in the treatment of recurrent Clostridium difficile.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL94
	answer	answer is ministerial correction date of answer 26/05/2016 answer text <p>The National Institute for Health and Care Excellence has produced guidance on faecal microbiota transplant for recurrent <em>Clostridium difficile</em> infection under the interventional procedure programme. This programme makes recommendations about the safety of the procedures and how well they work. However the guidance does not constitute a direction to National Health Service trusts to provide the interventions. Decisions about whether to provide a treatment are taken locally.</p> answering member printed Lord Prior of Brampton grouped question UIN HL97 question first answered 26/05/2016 16:29:01 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

76618

	registered interest
	date	09/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Neurofibromatosis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what plans they have to develop a national service framework for neurofibromatosis Type 1 sufferers.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL960
	answer	answer is ministerial correction date of answer 14/07/2014 answer text <p>The number of people with neurofibromatosis type 1 (NF1) in England is estimated to number 11,267. The condition can be mild in some patients, manifesting itself only in patches of skin discolouration and soft benign bumps under the skin (neurofibromas), but for others NF1 causes more serious complications, including a rare form of cancer, curvature of the spine and nerve problems caused by more invasive neurofibromas.</p><p> </p><p>Since 1 April 2013, NHS England has been responsible for securing high quality care for all patients with complex NF1 as part of its specialised commissioning responsibilities. NHS England's NF1 service specification clearly sets out what needs to be in place for providers to offer evidence-based, safe and effective care, ensuring equity of access to a nationally consistent, high quality service. Specialist care is delivered by two designated centres based in Manchester (Central Manchester University Hospitals NHS Foundation Trust) and London (Guys and St. Thomas' NHS Foundation Trust, London) and these provide outreach support into other cities. The service is available to all patients with a suspected or confirmed diagnosis of NF1.</p><p> </p><p>The service specification can be viewed on the NHS England website at the following link:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/b13-comp-neurofib-1.pdf.</p> answering member printed Earl Howe grouped question UIN HL961 HL962 question first answered 14/07/2014 16:18:37 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

76619

	registered interest
	date	09/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Neurofibromatosis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how they will ensure a co-ordinated response at local level for neurofibromatosis Type 1 sufferers.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL961
	answer	answer is ministerial correction date of answer 14/07/2014 answer text <p>The number of people with neurofibromatosis type 1 (NF1) in England is estimated to number 11,267. The condition can be mild in some patients, manifesting itself only in patches of skin discolouration and soft benign bumps under the skin (neurofibromas), but for others NF1 causes more serious complications, including a rare form of cancer, curvature of the spine and nerve problems caused by more invasive neurofibromas.</p><p> </p><p>Since 1 April 2013, NHS England has been responsible for securing high quality care for all patients with complex NF1 as part of its specialised commissioning responsibilities. NHS England's NF1 service specification clearly sets out what needs to be in place for providers to offer evidence-based, safe and effective care, ensuring equity of access to a nationally consistent, high quality service. Specialist care is delivered by two designated centres based in Manchester (Central Manchester University Hospitals NHS Foundation Trust) and London (Guys and St. Thomas' NHS Foundation Trust, London) and these provide outreach support into other cities. The service is available to all patients with a suspected or confirmed diagnosis of NF1.</p><p> </p><p>The service specification can be viewed on the NHS England website at the following link:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/b13-comp-neurofib-1.pdf.</p> answering member printed Earl Howe grouped question UIN HL960 HL962 question first answered 14/07/2014 16:18:38 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

76620

	registered interest
	date	09/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Neurofibromatosis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what is the scale of neurofibromatosis Type 1 in the United Kingdom.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL962
	answer	answer is ministerial correction date of answer 14/07/2014 answer text <p>The number of people with neurofibromatosis type 1 (NF1) in England is estimated to number 11,267. The condition can be mild in some patients, manifesting itself only in patches of skin discolouration and soft benign bumps under the skin (neurofibromas), but for others NF1 causes more serious complications, including a rare form of cancer, curvature of the spine and nerve problems caused by more invasive neurofibromas.</p><p> </p><p>Since 1 April 2013, NHS England has been responsible for securing high quality care for all patients with complex NF1 as part of its specialised commissioning responsibilities. NHS England's NF1 service specification clearly sets out what needs to be in place for providers to offer evidence-based, safe and effective care, ensuring equity of access to a nationally consistent, high quality service. Specialist care is delivered by two designated centres based in Manchester (Central Manchester University Hospitals NHS Foundation Trust) and London (Guys and St. Thomas' NHS Foundation Trust, London) and these provide outreach support into other cities. The service is available to all patients with a suspected or confirmed diagnosis of NF1.</p><p> </p><p>The service specification can be viewed on the NHS England website at the following link:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/b13-comp-neurofib-1.pdf.</p> answering member printed Earl Howe grouped question UIN HL960 HL961 question first answered 14/07/2014 16:18:38 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

518801

	registered interest
	date	18/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prime Minister: Ministerial Policy Advisers
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of the outcome and cost effectiveness of the use of faecal microbiota transplants in the treatment of recurrent Clostridium difficile infections.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL95
	answer	answer is ministerial correction date of answer 26/05/2016 answer text <p>The National Institute for Health and Care Excellence (NICE) has produced guidance on faecal microbiota transplant for recurrent <em>Clostridium difficile</em> infection. NICE has recommended that the procedure is safe enough for use in the National Health Service, but no assessment of its cost effectiveness has been made by NICE.</p><p> </p><p>Data on the uptake by the NHS of faecal microbiota transplants in the treatment of recurrent <em>Clostridium difficile</em> is not collected centrally.</p> answering member printed Lord Prior of Brampton grouped question UIN HL96 question first answered 26/05/2016 16:25:27 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

518802

	registered interest
	date	18/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Burial and Cremation
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of the rate of uptake by the NHS of faecal microbiota transplants in the treatment of recurrent Clostridium difficile infections.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL96
	answer	answer is ministerial correction date of answer 26/05/2016 answer text <p>The National Institute for Health and Care Excellence (NICE) has produced guidance on faecal microbiota transplant for recurrent <em>Clostridium difficile</em> infection. NICE has recommended that the procedure is safe enough for use in the National Health Service, but no assessment of its cost effectiveness has been made by NICE.</p><p> </p><p>Data on the uptake by the NHS of faecal microbiota transplants in the treatment of recurrent <em>Clostridium difficile</em> is not collected centrally.</p> answering member printed Lord Prior of Brampton grouped question UIN HL95 question first answered 26/05/2016 16:25:27 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

518803

	registered interest
	date	18/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prime Minister: Ministerial Policy Advisers
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what action they are taking to ensure that NICE guidance is followed in the use of faecal microbiota transplants in the treatment of recurrent Clostridium difficile infections.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL97
	answer	answer is ministerial correction date of answer 26/05/2016 answer text <p>The National Institute for Health and Care Excellence has produced guidance on faecal microbiota transplant for recurrent <em>Clostridium difficile</em> infection under the interventional procedure programme. This programme makes recommendations about the safety of the procedures and how well they work. However the guidance does not constitute a direction to National Health Service trusts to provide the interventions. Decisions about whether to provide a treatment are taken locally.</p> answering member printed Lord Prior of Brampton grouped question UIN HL94 question first answered 26/05/2016 16:29:01 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

347224

	registered interest
	date	28/05/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services: Staffordshire
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what action they are taking to ensure the viability of comprehensive patient services in the Staffordshire local health economy.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL88
	answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>NHS England has identified the Staffordshire clinical commissioning groups (CCGs) as high risk, and as such is monitoring their performance on a monthly basis with a full quarterly review of finance and performance. NHS England increases the intensity of performance reviews where there are significant shortfalls. This includes weekly meetings with CCGs where appropriate.</p><p> </p><p> </p><p> </p><p>Collaborative working relationships are a critical factor in securing sustainable services in any local health economy. The Commissioning Congress has been set up in Staffordshire to bring together both CCGs and local authority commissioners. The Congress will lead the Transformation Strategy which will drive the service redesign of the Staffordshire Health and Social Care economy to secure financial and clinically sustainable services in the long term. The Congress will engage with local providers in developing these plans to ensure that there is a single five-year plan for the local health economy. This work will lead to a full public consultation on those services during the autumn of 2015.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p>The Congress brings together the combined skills, knowledge and expertise of commissioners to work the provider sector on defining the range, scale and scope of services changes to ensure Staffordshire is both clinically and financially sustainable in the long term.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL90 HL91 HL92 HL93 question first answered 09/06/2015 12:42:46 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

752441

	registered interest
	date	17/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government which organisation is responsible for ensuring that a paediatric audiology service that has not met the standards for Improving Quality in Physiological Services (IQIPS) accreditation addresses the problems found during the accreditation visit.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL887
	answer	answer is ministerial correction date of answer 20/07/2017 answer text <p>The Improving Quality in Physiological Services (IQIPS) accreditation scheme is run by the United Kingdom Accreditation Service (UKAS). The process of accreditation provides an independent assessment that a service meets the accreditation standards.</p><p> </p><p>It is the responsibility of the service to ensure that they conform to the standard before application to UKAS for accreditation. There is a pre-registration process within the scheme that enables all services to be able to do an effective gap analysis so that they should be at a point of conforming to the standard on making an application to UKAS. If during an assessment mandatory findings are raised which show non-conformity to any part of the standard then the service agrees appropriate improvement actions with the UKAS team to rectify these and prevent re-occurrence.</p><p> </p><p>The UKAS team base their recommendation for accreditation on the findings raised relating to the conformity to the standard, risk and whether the agreed improvement actions are appropriate and can be achieved within a three month close-out period. Therefore any findings raised must be cleared by the organisation if a positive recommendation for accreditation is to be granted.</p><p> </p><p>In <em>Commissioning Services for People with Hearing Loss: A framework for clinical commissioning groups</em>, published in July 2016, NHS England strongly encourages clinical commissioning groups to expect providers to have completed the IQIPS self-assessment tool and applied for accreditation with UKAS, and achieve accreditation within the duration of their contract.</p><p> </p><p>UKAS are supporting the NHS England business objective to increase the use of accreditation, and information about those services which have achieved accreditation is not held by the Department or NHS England, but is publicly available on the UKAS website.</p><p> </p><p>Information on clinical contracts is not held centrally by NHS England.</p> answering member printed Baroness Chisholm of Owlpen grouped question UIN HL889 HL890 HL891 HL979 question first answered 20/07/2017 14:50:43 answering member 4330 label Biography information for Baroness Chisholm of Owlpen
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

752443

	registered interest
	date	17/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government how many NHS Trusts achieved Improving Quality in Physiological Services accreditation for their paediatric audiology service in each of the last five financial years.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL889
	answer	answer is ministerial correction date of answer 20/07/2017 answer text <p>The Improving Quality in Physiological Services (IQIPS) accreditation scheme is run by the United Kingdom Accreditation Service (UKAS). The process of accreditation provides an independent assessment that a service meets the accreditation standards.</p><p> </p><p>It is the responsibility of the service to ensure that they conform to the standard before application to UKAS for accreditation. There is a pre-registration process within the scheme that enables all services to be able to do an effective gap analysis so that they should be at a point of conforming to the standard on making an application to UKAS. If during an assessment mandatory findings are raised which show non-conformity to any part of the standard then the service agrees appropriate improvement actions with the UKAS team to rectify these and prevent re-occurrence.</p><p> </p><p>The UKAS team base their recommendation for accreditation on the findings raised relating to the conformity to the standard, risk and whether the agreed improvement actions are appropriate and can be achieved within a three month close-out period. Therefore any findings raised must be cleared by the organisation if a positive recommendation for accreditation is to be granted.</p><p> </p><p>In <em>Commissioning Services for People with Hearing Loss: A framework for clinical commissioning groups</em>, published in July 2016, NHS England strongly encourages clinical commissioning groups to expect providers to have completed the IQIPS self-assessment tool and applied for accreditation with UKAS, and achieve accreditation within the duration of their contract.</p><p> </p><p>UKAS are supporting the NHS England business objective to increase the use of accreditation, and information about those services which have achieved accreditation is not held by the Department or NHS England, but is publicly available on the UKAS website.</p><p> </p><p>Information on clinical contracts is not held centrally by NHS England.</p> answering member printed Baroness Chisholm of Owlpen grouped question UIN HL887 HL890 HL891 HL979 question first answered 20/07/2017 14:50:43 answering member 4330 label Biography information for Baroness Chisholm of Owlpen
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

752444

	registered interest
	date	17/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government how many contracts for Specialist Audiology Services used by children, and commissioned directly by NHS England, were signed in the financial years (1) 2015-16, and (2) 2016-17.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL890
	answer	answer is ministerial correction date of answer 20/07/2017 answer text <p>The Improving Quality in Physiological Services (IQIPS) accreditation scheme is run by the United Kingdom Accreditation Service (UKAS). The process of accreditation provides an independent assessment that a service meets the accreditation standards.</p><p> </p><p>It is the responsibility of the service to ensure that they conform to the standard before application to UKAS for accreditation. There is a pre-registration process within the scheme that enables all services to be able to do an effective gap analysis so that they should be at a point of conforming to the standard on making an application to UKAS. If during an assessment mandatory findings are raised which show non-conformity to any part of the standard then the service agrees appropriate improvement actions with the UKAS team to rectify these and prevent re-occurrence.</p><p> </p><p>The UKAS team base their recommendation for accreditation on the findings raised relating to the conformity to the standard, risk and whether the agreed improvement actions are appropriate and can be achieved within a three month close-out period. Therefore any findings raised must be cleared by the organisation if a positive recommendation for accreditation is to be granted.</p><p> </p><p>In <em>Commissioning Services for People with Hearing Loss: A framework for clinical commissioning groups</em>, published in July 2016, NHS England strongly encourages clinical commissioning groups to expect providers to have completed the IQIPS self-assessment tool and applied for accreditation with UKAS, and achieve accreditation within the duration of their contract.</p><p> </p><p>UKAS are supporting the NHS England business objective to increase the use of accreditation, and information about those services which have achieved accreditation is not held by the Department or NHS England, but is publicly available on the UKAS website.</p><p> </p><p>Information on clinical contracts is not held centrally by NHS England.</p> answering member printed Baroness Chisholm of Owlpen grouped question UIN HL887 HL889 HL891 HL979 question first answered 20/07/2017 14:50:43 answering member 4330 label Biography information for Baroness Chisholm of Owlpen
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

752445

	registered interest
	date	17/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government how many contracts for Specialist Audiology Services used by children, and commissioned directly by NHS England, are due to be renegotiated in the financial year 2017-18.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL891
	answer	answer is ministerial correction date of answer 20/07/2017 answer text <p>The Improving Quality in Physiological Services (IQIPS) accreditation scheme is run by the United Kingdom Accreditation Service (UKAS). The process of accreditation provides an independent assessment that a service meets the accreditation standards.</p><p> </p><p>It is the responsibility of the service to ensure that they conform to the standard before application to UKAS for accreditation. There is a pre-registration process within the scheme that enables all services to be able to do an effective gap analysis so that they should be at a point of conforming to the standard on making an application to UKAS. If during an assessment mandatory findings are raised which show non-conformity to any part of the standard then the service agrees appropriate improvement actions with the UKAS team to rectify these and prevent re-occurrence.</p><p> </p><p>The UKAS team base their recommendation for accreditation on the findings raised relating to the conformity to the standard, risk and whether the agreed improvement actions are appropriate and can be achieved within a three month close-out period. Therefore any findings raised must be cleared by the organisation if a positive recommendation for accreditation is to be granted.</p><p> </p><p>In <em>Commissioning Services for People with Hearing Loss: A framework for clinical commissioning groups</em>, published in July 2016, NHS England strongly encourages clinical commissioning groups to expect providers to have completed the IQIPS self-assessment tool and applied for accreditation with UKAS, and achieve accreditation within the duration of their contract.</p><p> </p><p>UKAS are supporting the NHS England business objective to increase the use of accreditation, and information about those services which have achieved accreditation is not held by the Department or NHS England, but is publicly available on the UKAS website.</p><p> </p><p>Information on clinical contracts is not held centrally by NHS England.</p> answering member printed Baroness Chisholm of Owlpen grouped question UIN HL887 HL889 HL890 HL979 question first answered 20/07/2017 14:50:43 answering member 4330 label Biography information for Baroness Chisholm of Owlpen
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

753291

	registered interest
	date	18/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government whether they intend to ensure that Clinical Commissioning Groups are notified when a paediatric audiology service does not meet the standards for Improving Quality in Physiological Services accreditation following an assessment visit.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL979
	answer	answer is ministerial correction date of answer 20/07/2017 answer text <p>The Improving Quality in Physiological Services (IQIPS) accreditation scheme is run by the United Kingdom Accreditation Service (UKAS). The process of accreditation provides an independent assessment that a service meets the accreditation standards.</p><p> </p><p>It is the responsibility of the service to ensure that they conform to the standard before application to UKAS for accreditation. There is a pre-registration process within the scheme that enables all services to be able to do an effective gap analysis so that they should be at a point of conforming to the standard on making an application to UKAS. If during an assessment mandatory findings are raised which show non-conformity to any part of the standard then the service agrees appropriate improvement actions with the UKAS team to rectify these and prevent re-occurrence.</p><p> </p><p>The UKAS team base their recommendation for accreditation on the findings raised relating to the conformity to the standard, risk and whether the agreed improvement actions are appropriate and can be achieved within a three month close-out period. Therefore any findings raised must be cleared by the organisation if a positive recommendation for accreditation is to be granted.</p><p> </p><p>In <em>Commissioning Services for People with Hearing Loss: A framework for clinical commissioning groups</em>, published in July 2016, NHS England strongly encourages clinical commissioning groups to expect providers to have completed the IQIPS self-assessment tool and applied for accreditation with UKAS, and achieve accreditation within the duration of their contract.</p><p> </p><p>UKAS are supporting the NHS England business objective to increase the use of accreditation, and information about those services which have achieved accreditation is not held by the Department or NHS England, but is publicly available on the UKAS website.</p><p> </p><p>Information on clinical contracts is not held centrally by NHS England.</p> answering member printed Baroness Chisholm of Owlpen grouped question UIN HL887 HL889 HL890 HL891 question first answered 20/07/2017 14:50:44 answering member 4330 label Biography information for Baroness Chisholm of Owlpen
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

347226

	registered interest
	date	28/05/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Commissioning Groups: Staffordshire
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of the conclusion drawn in the Staffordshire Distressed Health Economy report by KPMG that there is a lack of collaborative working across the six Clinical Commissioning Groups in Staffordshire to maximise leadership capabilities.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL90
	answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>NHS England has identified the Staffordshire clinical commissioning groups (CCGs) as high risk, and as such is monitoring their performance on a monthly basis with a full quarterly review of finance and performance. NHS England increases the intensity of performance reviews where there are significant shortfalls. This includes weekly meetings with CCGs where appropriate.</p><p> </p><p> </p><p> </p><p>Collaborative working relationships are a critical factor in securing sustainable services in any local health economy. The Commissioning Congress has been set up in Staffordshire to bring together both CCGs and local authority commissioners. The Congress will lead the Transformation Strategy which will drive the service redesign of the Staffordshire Health and Social Care economy to secure financial and clinically sustainable services in the long term. The Congress will engage with local providers in developing these plans to ensure that there is a single five-year plan for the local health economy. This work will lead to a full public consultation on those services during the autumn of 2015.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p>The Congress brings together the combined skills, knowledge and expertise of commissioners to work the provider sector on defining the range, scale and scope of services changes to ensure Staffordshire is both clinically and financially sustainable in the long term.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL88 HL91 HL92 HL93 question first answered 09/06/2015 12:42:46 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

347227

	registered interest
	date	28/05/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Commissioning Groups: Staffordshire
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, in the light of the Staffordshire Distressed Health Economy report by KPMG, what assessment they have made of whether NHS England has appropriately held the six Clinical Commissioning Groups in Staffordshire to account for their performance.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL91
	answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>NHS England has identified the Staffordshire clinical commissioning groups (CCGs) as high risk, and as such is monitoring their performance on a monthly basis with a full quarterly review of finance and performance. NHS England increases the intensity of performance reviews where there are significant shortfalls. This includes weekly meetings with CCGs where appropriate.</p><p> </p><p> </p><p> </p><p>Collaborative working relationships are a critical factor in securing sustainable services in any local health economy. The Commissioning Congress has been set up in Staffordshire to bring together both CCGs and local authority commissioners. The Congress will lead the Transformation Strategy which will drive the service redesign of the Staffordshire Health and Social Care economy to secure financial and clinically sustainable services in the long term. The Congress will engage with local providers in developing these plans to ensure that there is a single five-year plan for the local health economy. This work will lead to a full public consultation on those services during the autumn of 2015.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p>The Congress brings together the combined skills, knowledge and expertise of commissioners to work the provider sector on defining the range, scale and scope of services changes to ensure Staffordshire is both clinically and financially sustainable in the long term.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL88 HL90 HL92 HL93 question first answered 09/06/2015 12:42:47 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

347228

	registered interest
	date	28/05/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services: Staffordshire
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of whether there is alignment between all commissioner and provider plans in the Staffordshire local health economy.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL92
	answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>NHS England has identified the Staffordshire clinical commissioning groups (CCGs) as high risk, and as such is monitoring their performance on a monthly basis with a full quarterly review of finance and performance. NHS England increases the intensity of performance reviews where there are significant shortfalls. This includes weekly meetings with CCGs where appropriate.</p><p> </p><p> </p><p> </p><p>Collaborative working relationships are a critical factor in securing sustainable services in any local health economy. The Commissioning Congress has been set up in Staffordshire to bring together both CCGs and local authority commissioners. The Congress will lead the Transformation Strategy which will drive the service redesign of the Staffordshire Health and Social Care economy to secure financial and clinically sustainable services in the long term. The Congress will engage with local providers in developing these plans to ensure that there is a single five-year plan for the local health economy. This work will lead to a full public consultation on those services during the autumn of 2015.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p>The Congress brings together the combined skills, knowledge and expertise of commissioners to work the provider sector on defining the range, scale and scope of services changes to ensure Staffordshire is both clinically and financially sustainable in the long term.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL88 HL90 HL91 HL93 question first answered 09/06/2015 12:42:47 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

347229

	registered interest
	date	28/05/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services: Staffordshire
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether there is an agreed single strategic plan across the Staffordshire local health economy.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL93
	answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>NHS England has identified the Staffordshire clinical commissioning groups (CCGs) as high risk, and as such is monitoring their performance on a monthly basis with a full quarterly review of finance and performance. NHS England increases the intensity of performance reviews where there are significant shortfalls. This includes weekly meetings with CCGs where appropriate.</p><p> </p><p> </p><p> </p><p>Collaborative working relationships are a critical factor in securing sustainable services in any local health economy. The Commissioning Congress has been set up in Staffordshire to bring together both CCGs and local authority commissioners. The Congress will lead the Transformation Strategy which will drive the service redesign of the Staffordshire Health and Social Care economy to secure financial and clinically sustainable services in the long term. The Congress will engage with local providers in developing these plans to ensure that there is a single five-year plan for the local health economy. This work will lead to a full public consultation on those services during the autumn of 2015.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p>The Congress brings together the combined skills, knowledge and expertise of commissioners to work the provider sector on defining the range, scale and scope of services changes to ensure Staffordshire is both clinically and financially sustainable in the long term.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL88 HL90 HL91 HL92 question first answered 09/06/2015 12:42:47 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

65841

	registered interest
	date	03/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pharmaceutical Price Regulation Scheme
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how much rebate they have so far received from pharmaceutical companies under the new Pharmaceutical Price Regulation Scheme agreement.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL833
	answer	answer is ministerial correction date of answer 09/07/2014 answer text <p>The Department has received £74 million from members of the Pharmaceutical Price Regulation Scheme (PPRS) in respect of PPRS payments for the first quarter of the calendar year 2014. The Department intends to publish aggregate information on sales reports and payments made under the scheme on a quarterly basis. The first such publication was made on 30 June and can be found on the Government's website at:</p><p> </p><p>www.gov.uk/government/publications/pprs-quarterly-net-sales-and-payment-information</p><p> </p><p>In respect of England, the anticipated payments in 2014-15 have been passed on to NHS England through the Mandate and as such were included within commissioner allocations.</p><p> </p><p>The Government is committed to improving access to clinically and cost-effective medicines including innovative new medicines. As part of implementing the PPRS, NHS England and the Association of the British Pharmaceutical Industry are discussing how best to improve access to, and optimise patient outcomes from, these medicines.</p> answering member printed Earl Howe grouped question UIN HL834 HL835 question first answered 09/07/2014 15:18:03 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

65842

	registered interest
	date	03/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pharmaceutical Price Regulation Scheme
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether the rebate they receive from pharmaceutical companies under the new Pharmaceutical Price Regulation Scheme agreement will be reallocated as an additional resource to the National Health Service.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL834
	answer	answer is ministerial correction date of answer 09/07/2014 answer text <p>The Department has received £74 million from members of the Pharmaceutical Price Regulation Scheme (PPRS) in respect of PPRS payments for the first quarter of the calendar year 2014. The Department intends to publish aggregate information on sales reports and payments made under the scheme on a quarterly basis. The first such publication was made on 30 June and can be found on the Government's website at:</p><p> </p><p>www.gov.uk/government/publications/pprs-quarterly-net-sales-and-payment-information</p><p> </p><p>In respect of England, the anticipated payments in 2014-15 have been passed on to NHS England through the Mandate and as such were included within commissioner allocations.</p><p> </p><p>The Government is committed to improving access to clinically and cost-effective medicines including innovative new medicines. As part of implementing the PPRS, NHS England and the Association of the British Pharmaceutical Industry are discussing how best to improve access to, and optimise patient outcomes from, these medicines.</p> answering member printed Earl Howe grouped question UIN HL833 HL835 question first answered 09/07/2014 15:18:04 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

65843

	registered interest
	date	03/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pharmaceutical Price Regulation Scheme
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government to what extent they propose to use the rebate they expect to receive from pharmaceutical companies under the new Pharmaceutical Price Regulation Scheme agreement to invest in innovative new medicines and procedures.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL835
	answer	answer is ministerial correction date of answer 09/07/2014 answer text <p>The Department has received £74 million from members of the Pharmaceutical Price Regulation Scheme (PPRS) in respect of PPRS payments for the first quarter of the calendar year 2014. The Department intends to publish aggregate information on sales reports and payments made under the scheme on a quarterly basis. The first such publication was made on 30 June and can be found on the Government's website at:</p><p> </p><p>www.gov.uk/government/publications/pprs-quarterly-net-sales-and-payment-information</p><p> </p><p>In respect of England, the anticipated payments in 2014-15 have been passed on to NHS England through the Mandate and as such were included within commissioner allocations.</p><p> </p><p>The Government is committed to improving access to clinically and cost-effective medicines including innovative new medicines. As part of implementing the PPRS, NHS England and the Association of the British Pharmaceutical Industry are discussing how best to improve access to, and optimise patient outcomes from, these medicines.</p> answering member printed Earl Howe grouped question UIN HL833 HL834 question first answered 09/07/2014 15:18:04 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

518085

	registered interest
	date	09/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Pharmacologists
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of the impact on the NHS of the predicted loss of 35 per cent of current clinical pharmacologist consultant posts through retirements in the next decade and the reduction in the number of training grade clinical pharmacologist posts, as set out in the report by the British Pharmacological Society, <i>A Prescription for the NHS: Recognising the value of clinical pharmacology and therapeutics</i>.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8246
	answer	answer is ministerial correction date of answer 12/05/2016 answer text <p>Figures published by the Health and Social Care Information Centre show that there has not been a reduction in the number of consultant clinical pharmacologists employed in the National Health Service in England.</p><p> </p><p>As part of its workforce planning, Health Education England (HEE) take account of a range of factors including forecast rates of retirement. HEE has recently undertaken a review of the clinical pharmacology and therapeutics workforce, the findings of which will contribute to future workforce planning for this specialty in England.</p><p> </p><p>It is for the respective Governments in Scotland, Wales and Northern Ireland to consider workforce planning for their health system.</p> answering member printed Lord Prior of Brampton grouped question UIN HL8247 HL8248 HL8249 HL8250 HL8251 question first answered 12/05/2016 10:05:25 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

518086

	registered interest
	date	09/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Pharmacologists
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of the reasons behind the reduction in the number of consultant clinical pharmacologist posts within the NHS.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8247
	answer	answer is ministerial correction date of answer 12/05/2016 answer text <p>Figures published by the Health and Social Care Information Centre show that there has not been a reduction in the number of consultant clinical pharmacologists employed in the National Health Service in England.</p><p> </p><p>As part of its workforce planning, Health Education England (HEE) take account of a range of factors including forecast rates of retirement. HEE has recently undertaken a review of the clinical pharmacology and therapeutics workforce, the findings of which will contribute to future workforce planning for this specialty in England.</p><p> </p><p>It is for the respective Governments in Scotland, Wales and Northern Ireland to consider workforce planning for their health system.</p> answering member printed Lord Prior of Brampton grouped question UIN HL8246 HL8248 HL8249 HL8250 HL8251 question first answered 12/05/2016 10:05:25 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

518087

	registered interest
	date	09/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Pharmacologists
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of the impact on the UK's research capacity of the reduction in the number of consultant clinical pharmacologist posts within the NHS.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8248
	answer	answer is ministerial correction date of answer 12/05/2016 answer text <p>Figures published by the Health and Social Care Information Centre show that there has not been a reduction in the number of consultant clinical pharmacologists employed in the National Health Service in England.</p><p> </p><p>As part of its workforce planning, Health Education England (HEE) take account of a range of factors including forecast rates of retirement. HEE has recently undertaken a review of the clinical pharmacology and therapeutics workforce, the findings of which will contribute to future workforce planning for this specialty in England.</p><p> </p><p>It is for the respective Governments in Scotland, Wales and Northern Ireland to consider workforce planning for their health system.</p> answering member printed Lord Prior of Brampton grouped question UIN HL8246 HL8247 HL8249 HL8250 HL8251 question first answered 12/05/2016 10:05:25 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

518088

	registered interest
	date	09/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Pharmacologists
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of the impact on the design and running of early phase clinical trials and all phases of drugs development of the reduction in the number of consultant clinical pharmacologist posts being held in the NHS.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8249
	answer	answer is ministerial correction date of answer 12/05/2016 answer text <p>Figures published by the Health and Social Care Information Centre show that there has not been a reduction in the number of consultant clinical pharmacologists employed in the National Health Service in England.</p><p> </p><p>As part of its workforce planning, Health Education England (HEE) take account of a range of factors including forecast rates of retirement. HEE has recently undertaken a review of the clinical pharmacology and therapeutics workforce, the findings of which will contribute to future workforce planning for this specialty in England.</p><p> </p><p>It is for the respective Governments in Scotland, Wales and Northern Ireland to consider workforce planning for their health system.</p> answering member printed Lord Prior of Brampton grouped question UIN HL8246 HL8247 HL8248 HL8250 HL8251 question first answered 12/05/2016 10:05:25 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

518089

	registered interest
	date	09/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Pharmacologists
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of the impact on medicines policy and management of the reduction in the number of consultant clinical pharmacologist posts within the NHS.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8250
	answer	answer is ministerial correction date of answer 12/05/2016 answer text <p>Figures published by the Health and Social Care Information Centre show that there has not been a reduction in the number of consultant clinical pharmacologists employed in the National Health Service in England.</p><p> </p><p>As part of its workforce planning, Health Education England (HEE) take account of a range of factors including forecast rates of retirement. HEE has recently undertaken a review of the clinical pharmacology and therapeutics workforce, the findings of which will contribute to future workforce planning for this specialty in England.</p><p> </p><p>It is for the respective Governments in Scotland, Wales and Northern Ireland to consider workforce planning for their health system.</p> answering member printed Lord Prior of Brampton grouped question UIN HL8246 HL8247 HL8248 HL8249 HL8251 question first answered 12/05/2016 10:05:25 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

518090

	registered interest
	date	09/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Pharmacologists
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what discussions they have had with Health Education England over any action required to stem the loss of consultant clinical pharmacologist posts in the NHS.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8251
	answer	answer is ministerial correction date of answer 12/05/2016 answer text <p>Figures published by the Health and Social Care Information Centre show that there has not been a reduction in the number of consultant clinical pharmacologists employed in the National Health Service in England.</p><p> </p><p>As part of its workforce planning, Health Education England (HEE) take account of a range of factors including forecast rates of retirement. HEE has recently undertaken a review of the clinical pharmacology and therapeutics workforce, the findings of which will contribute to future workforce planning for this specialty in England.</p><p> </p><p>It is for the respective Governments in Scotland, Wales and Northern Ireland to consider workforce planning for their health system.</p> answering member printed Lord Prior of Brampton grouped question UIN HL8246 HL8247 HL8248 HL8249 HL8250 question first answered 12/05/2016 10:05:25 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

517585

	registered interest
	date	04/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Reorganisation
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what formal public consultation will need to take place before Sustainability and Transformation Plans are submitted to NHS England by 30 June.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8178
	answer	answer is ministerial correction date of answer 10/05/2016 answer text <p>Where Sustainability and Transformation plans envisage changes to the way that NHS services are commissioned or delivered, it will be the responsibility of the relevant clinical commissioning groups to involve patients and the public in considering and making decisions on those proposals, in line with their duties under the National Health Service Act 2006.</p> answering member printed Lord Prior of Brampton grouped question UIN HL8179 question first answered 10/05/2016 12:57:02 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

517586

	registered interest
	date	04/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Reorganisation
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what formal public consultation will need to take place when Sustainability and Transformation Plans are given approval by NHS England.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8179
	answer	answer is ministerial correction date of answer 10/05/2016 answer text <p>Where Sustainability and Transformation plans envisage changes to the way that NHS services are commissioned or delivered, it will be the responsibility of the relevant clinical commissioning groups to involve patients and the public in considering and making decisions on those proposals, in line with their duties under the National Health Service Act 2006.</p> answering member printed Lord Prior of Brampton grouped question UIN HL8178 question first answered 10/05/2016 12:57:02 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

516965

	registered interest
	date	03/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Out-patients: Waiting Lists
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what mechanisms are in place to safeguard patients from delays to return hospital appointments beyond the clinically recommended time.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8121
	answer	answer is ministerial correction date of answer 11/05/2016 answer text <p>All follow up appointments (also known as planned, surveillance or recall appointments) should take place when clinically appropriate. It is for clinicians to make decisions on when they see patients, in line with their clinical priority, and patients should not experience undue delay at any stage of their referral, diagnosis or treatment. Moreover, the appropriate interval for follow up appointments will vary between different services or specialties, and between individual patients, depending on the severity of their condition.</p><p> </p><p>To ensure that patients are seen at the appropriate time, NHS England guidance is clear that when patients on planned lists are clinically ready for their care to commence and reach the date for their planned appointment, they should either receive that appointment or be transferred to an active waiting list. At that point, a waiting time clock will be started and their wait reported in the relevant statistical return, so that patients are not waiting on ‘hidden’ lists.</p><p> </p><p>Furthermore, the Care Quality Commission (CQC) also assesses providers against the new fundamental standards of safety and quality below which care should never fail. One of these standards requires that care and treatment must be appropriate and reflect service users’ needs and preferences. Another requires that care and treatment must be provided in a safe way. The CQC will require a provider to improve where it is not meeting these standards.</p><p> </p><p>No assessment has been made of the clinical risks to patients of follow-up appointments being scheduled beyond clinically recommended times, as the risks will also vary between services, specialties and patients. It is for clinicians to make these judgements.</p><p> </p><p>The information requested on delays to review outpatient appointments is not collected centrally.</p> answering member printed Lord Prior of Brampton grouped question UIN HL8122 HL8123 question first answered 11/05/2016 15:59:51 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

516966

	registered interest
	date	03/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Out-patients: Waiting Lists
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of the clinical risks to patients of follow-up appointments being scheduled beyond clinically recommended times.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8122
	answer	answer is ministerial correction date of answer 11/05/2016 answer text <p>All follow up appointments (also known as planned, surveillance or recall appointments) should take place when clinically appropriate. It is for clinicians to make decisions on when they see patients, in line with their clinical priority, and patients should not experience undue delay at any stage of their referral, diagnosis or treatment. Moreover, the appropriate interval for follow up appointments will vary between different services or specialties, and between individual patients, depending on the severity of their condition.</p><p> </p><p>To ensure that patients are seen at the appropriate time, NHS England guidance is clear that when patients on planned lists are clinically ready for their care to commence and reach the date for their planned appointment, they should either receive that appointment or be transferred to an active waiting list. At that point, a waiting time clock will be started and their wait reported in the relevant statistical return, so that patients are not waiting on ‘hidden’ lists.</p><p> </p><p>Furthermore, the Care Quality Commission (CQC) also assesses providers against the new fundamental standards of safety and quality below which care should never fail. One of these standards requires that care and treatment must be appropriate and reflect service users’ needs and preferences. Another requires that care and treatment must be provided in a safe way. The CQC will require a provider to improve where it is not meeting these standards.</p><p> </p><p>No assessment has been made of the clinical risks to patients of follow-up appointments being scheduled beyond clinically recommended times, as the risks will also vary between services, specialties and patients. It is for clinicians to make these judgements.</p><p> </p><p>The information requested on delays to review outpatient appointments is not collected centrally.</p> answering member printed Lord Prior of Brampton grouped question UIN HL8121 HL8123 question first answered 11/05/2016 15:59:51 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

516967

	registered interest
	date	03/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Out-patients: Waiting lists
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government how many review outpatient appointments were delayed beyond the clinically recommended time by hospitals in (1) 2014–15, and (2) 2015–16.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8123
	answer	answer is ministerial correction date of answer 11/05/2016 answer text <p>All follow up appointments (also known as planned, surveillance or recall appointments) should take place when clinically appropriate. It is for clinicians to make decisions on when they see patients, in line with their clinical priority, and patients should not experience undue delay at any stage of their referral, diagnosis or treatment. Moreover, the appropriate interval for follow up appointments will vary between different services or specialties, and between individual patients, depending on the severity of their condition.</p><p> </p><p>To ensure that patients are seen at the appropriate time, NHS England guidance is clear that when patients on planned lists are clinically ready for their care to commence and reach the date for their planned appointment, they should either receive that appointment or be transferred to an active waiting list. At that point, a waiting time clock will be started and their wait reported in the relevant statistical return, so that patients are not waiting on ‘hidden’ lists.</p><p> </p><p>Furthermore, the Care Quality Commission (CQC) also assesses providers against the new fundamental standards of safety and quality below which care should never fail. One of these standards requires that care and treatment must be appropriate and reflect service users’ needs and preferences. Another requires that care and treatment must be provided in a safe way. The CQC will require a provider to improve where it is not meeting these standards.</p><p> </p><p>No assessment has been made of the clinical risks to patients of follow-up appointments being scheduled beyond clinically recommended times, as the risks will also vary between services, specialties and patients. It is for clinicians to make these judgements.</p><p> </p><p>The information requested on delays to review outpatient appointments is not collected centrally.</p> answering member printed Lord Prior of Brampton grouped question UIN HL8121 HL8122 question first answered 11/05/2016 15:59:51 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

516383

	registered interest
	date	27/04/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clostridium
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of (1) the outcome, and (2) the cost effectiveness, of the use of faecal microbiota transplants in the treatment of recurrent clostridium difficile.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8021
	answer	answer is ministerial correction date of answer 06/05/2016 answer text <p>The National Institute for Health and Care Excellence (NICE) has produced guidance on faecal microbiota transplant for recurrent <em>Clostridium difficile</em> infection. NICE has recommended that the procedure is safe and effective for use in the National Health Service, but no assessment of its cost effectiveness has been made by NICE.</p><p> </p><p>Data on the uptake of faecal microbiota transplants in the treatment of recurrent <em>Clostridium difficile</em> by the NHS is not collected centrally.</p> answering member printed Lord Prior of Brampton grouped question UIN HL8022 question first answered 06/05/2016 12:47:17 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

516384

	registered interest
	date	27/04/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clostridium
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of the rate of uptake by the NHS of faecal microbiota transplants in the treatment of recurrent clostridium difficile.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8022
	answer	answer is ministerial correction date of answer 06/05/2016 answer text <p>The National Institute for Health and Care Excellence (NICE) has produced guidance on faecal microbiota transplant for recurrent <em>Clostridium difficile</em> infection. NICE has recommended that the procedure is safe and effective for use in the National Health Service, but no assessment of its cost effectiveness has been made by NICE.</p><p> </p><p>Data on the uptake of faecal microbiota transplants in the treatment of recurrent <em>Clostridium difficile</em> by the NHS is not collected centrally.</p> answering member printed Lord Prior of Brampton grouped question UIN HL8021 question first answered 06/05/2016 12:47:17 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

516379

	registered interest
	date	27/04/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	HIV Infection: Drugs
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of the effectiveness of pre-exposure prophylaxis in the prevention of HIV.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8017
	answer	answer is ministerial correction date of answer 11/05/2016 answer text <p>Pre-exposure prophylaxis (PrEP) is a new use of HIV drugs which has shown clinical effectiveness in research trials at preventing HIV in people at high risk of getting HIV such as men who have sex with men (MSM) and people with HIV-positive partners. The drug used in the trials, Truvada, is not yet licenced for use as PrEP. Public Health England (PHE) has undertaken modelling work looking at cost-effectiveness of PrEP. Much depends on the price of the drugs and HIV prevalence in the target group. However, as with any new intervention, PrEP now needs to be properly assessed in relation to cost effectiveness to see how it could be commissioned in the most sustainable and integrated way and how it compares with other cost-effective approaches. The Department is considering this with PHE, NHS England and the National Institute for Health and Care Excellence.</p><p> </p><p>NHS England has agreed to carefully consider their position on commissioning pre-exposure prophylaxis (PrEP). Planning continues on the early implementer tests sites in the meantime. Irrespective of the commissioning arrangements for PrEP, decisions to fund will depend on full assessment of clinical and cost effectiveness and how it can be integrated with other HIV prevention efforts.</p> answering member printed Lord Prior of Brampton grouped question UIN HL8018 question first answered 11/05/2016 15:48:45 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

516380

	registered interest
	date	27/04/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	HIV Infection: Drugs
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government why NHS England has refused to pay the costs of making available pre-exposure prophylaxis in order to protect men from HIV.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8018
	answer	answer is ministerial correction date of answer 11/05/2016 answer text <p>Pre-exposure prophylaxis (PrEP) is a new use of HIV drugs which has shown clinical effectiveness in research trials at preventing HIV in people at high risk of getting HIV such as men who have sex with men (MSM) and people with HIV-positive partners. The drug used in the trials, Truvada, is not yet licenced for use as PrEP. Public Health England (PHE) has undertaken modelling work looking at cost-effectiveness of PrEP. Much depends on the price of the drugs and HIV prevalence in the target group. However, as with any new intervention, PrEP now needs to be properly assessed in relation to cost effectiveness to see how it could be commissioned in the most sustainable and integrated way and how it compares with other cost-effective approaches. The Department is considering this with PHE, NHS England and the National Institute for Health and Care Excellence.</p><p> </p><p>NHS England has agreed to carefully consider their position on commissioning pre-exposure prophylaxis (PrEP). Planning continues on the early implementer tests sites in the meantime. Irrespective of the commissioning arrangements for PrEP, decisions to fund will depend on full assessment of clinical and cost effectiveness and how it can be integrated with other HIV prevention efforts.</p> answering member printed Lord Prior of Brampton grouped question UIN HL8017 question first answered 11/05/2016 15:48:45 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

346841

	registered interest
	date	27/05/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services: Staffordshire
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether they agree with the assessment of the Staffordshire Distressed Health Economy report by KPMG into the Staffordshire local health economy that the annual financial deficit across the NHS providers and commissioners in Staffordshire could reach £216.8m by 2018–19.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL79
	answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>There are significant financial issues within Staffordshire which present a challenge for the local leaders.</p><p> </p><p> </p><p> </p><p>The financial challenge is being addressed by the Transformation Strategy which will drive the service redesign of the Staffordshire health and social care economy to secure financial and clinically sustainable services in the long term. This work is being led by the Clinical Commissioning Congress - a joint body of clinical commissioning Groups and local authority commissioners.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL80 question first answered 09/06/2015 12:40:04 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

515541

	registered interest
	date	25/04/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	General Dental Council
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of the open letter from the British Dental Association to the Chairman of the General Dental Council (GDC) of 1 April on the GDC's spending on external legal advice, redundancy payments and related external PR services during the Professional Services Authority whistle-blowing inquiry, and what action they intend to take in the light of that assessment.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL7921
	answer	answer is ministerial correction date of answer 04/05/2016 answer text <p>The General Dental Council (GDC) is an independent statutory body. Ministers take a keen interest in the performance of the GDC and its plans for improvement, particularly in light of the Professional Standards Authority’s (PSA) performance review and publication of its investigation into concerns raised by a whistleblower. A copy of the PSA’s report, <em>A report on the investigation into the General Dental Council’s handling of a whistleblower’s disclosure about the Investigating Committee</em>, is attached.</p><p> </p><p>The GDC is required under the Dentist Act 1984 to prepare a statement of accounts and for those accounts to be audited. These accounts would cover all expenditure including that during the PSA investigation. The statement of accounts and auditor’s report are then published and properly scrutinised, including being certified and reported on by the Controller and Auditor General and being laid before Parliament and the Scottish Parliament by the Privy Council.</p><p> </p><p>The Department has no plans to ask the National Audit Office to carry out a value for money examination of the GDC’s financial management.</p> answering member printed Lord Prior of Brampton grouped question UIN HL7922 question first answered 04/05/2016 11:08:49 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name PSA investigation-report---general-dental-council.pdf title General Dental Council PSA report
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

515542

	registered interest
	date	25/04/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	General Dental Council
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, in the light of the General Dental Council’s (GDC) response to the British Dental Association’s Freedom of Information request of 18 March, whether they will ask the National Audit Office to carry out a value-for-money examination of GDC’s financial management.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL7922
	answer	answer is ministerial correction date of answer 04/05/2016 answer text <p>The General Dental Council (GDC) is an independent statutory body. Ministers take a keen interest in the performance of the GDC and its plans for improvement, particularly in light of the Professional Standards Authority’s (PSA) performance review and publication of its investigation into concerns raised by a whistleblower. A copy of the PSA’s report, <em>A report on the investigation into the General Dental Council’s handling of a whistleblower’s disclosure about the Investigating Committee</em>, is attached.</p><p> </p><p>The GDC is required under the Dentist Act 1984 to prepare a statement of accounts and for those accounts to be audited. These accounts would cover all expenditure including that during the PSA investigation. The statement of accounts and auditor’s report are then published and properly scrutinised, including being certified and reported on by the Controller and Auditor General and being laid before Parliament and the Scottish Parliament by the Privy Council.</p><p> </p><p>The Department has no plans to ask the National Audit Office to carry out a value for money examination of the GDC’s financial management.</p> answering member printed Lord Prior of Brampton grouped question UIN HL7921 question first answered 04/05/2016 11:08:49 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name PSA investigation-report---general-dental-council.pdf title General Dental Council PSA report
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

346842

	registered interest
	date	27/05/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services: Staffordshire
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what steps they are taking to ensure the financial viability of the Staffordshire local health economy.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL80
	answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>There are significant financial issues within Staffordshire which present a challenge for the local leaders.</p><p> </p><p> </p><p> </p><p>The financial challenge is being addressed by the Transformation Strategy which will drive the service redesign of the Staffordshire health and social care economy to secure financial and clinically sustainable services in the long term. This work is being led by the Clinical Commissioning Congress - a joint body of clinical commissioning Groups and local authority commissioners.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL79 question first answered 09/06/2015 12:40:04 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

385295

	registered interest
	date	24/06/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Commissioning Groups
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what action they plan to take in the event of the Clinical Commissioning Groups outsourcing parts of their commissioning role to get round the restrictions on administrative costs.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL778
	answer	answer is ministerial correction date of answer 29/06/2015 answer text <p>Clinical commissioning groups (CCGs), as independent statutory bodies, can choose how best to carry out their commissioning functions from within their running cost budget.</p><p> </p><p> </p><p> </p><p>Where CCGs choose to outsource their support and to buy from external providers, this funding will be charged against their fixed running cost allowance.</p><p> </p><p> </p><p> </p><p>Service integrators and lead providers co-ordinate and provide care for patients; they are not commissioners, nor do they undertake commissioning activities or responsibilities.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL779 HL780 question first answered 29/06/2015 15:05:34 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

385296

	registered interest
	date	24/06/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Commissioning Groups
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government, when Clinical Commissioning Groups outsource some of their commissioning role to integrators, lead providers or through other similar mechanisms, how the administrative costs so transferred will be counted against the Clinical Commissioning Groups' administrative cost cap.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL779
	answer	answer is ministerial correction date of answer 29/06/2015 answer text <p>Clinical commissioning groups (CCGs), as independent statutory bodies, can choose how best to carry out their commissioning functions from within their running cost budget.</p><p> </p><p> </p><p> </p><p>Where CCGs choose to outsource their support and to buy from external providers, this funding will be charged against their fixed running cost allowance.</p><p> </p><p> </p><p> </p><p>Service integrators and lead providers co-ordinate and provide care for patients; they are not commissioners, nor do they undertake commissioning activities or responsibilities.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL778 HL780 question first answered 29/06/2015 15:05:33 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

385297

	registered interest
	date	24/06/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Commissioning Groups
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether, when Clinical Commissioning Groups outsource some of their commissioning role, the element of administration that would have counted towards the fixed cap on administrative costs will be separately identified and appropriately deducted from Clinical Commissioning Group budgets.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL780
	answer	answer is ministerial correction date of answer 29/06/2015 answer text <p>Clinical commissioning groups (CCGs), as independent statutory bodies, can choose how best to carry out their commissioning functions from within their running cost budget.</p><p> </p><p> </p><p> </p><p>Where CCGs choose to outsource their support and to buy from external providers, this funding will be charged against their fixed running cost allowance.</p><p> </p><p> </p><p> </p><p>Service integrators and lead providers co-ordinate and provide care for patients; they are not commissioners, nor do they undertake commissioning activities or responsibilities.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL778 HL779 question first answered 29/06/2015 15:05:34 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

513440

	registered interest
	date	18/04/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Ophthalmology
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of how many patients have lost their vision as a result of not receiving timely follow-up appointments to see an ophthalmic specialist.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL7697
	answer	answer is ministerial correction date of answer 03/05/2016 answer text <p>Given the size of England, and the diversity of the health needs of different communities, we believe commissioning needs to be owned and managed locally.</p><p>Therefore, there are no plans to develop a national strategy for eye care.</p><p> </p><p>Clinical commissioning groups (CCGs) are responsible for commissioning hospital eye services and for holding their providers to account in terms of contract performance. CCGs are also able to commission eye care services from community optometrists where they judge them to be needed in their areas over and above the sight tests commissioned by NHS England. Such services could include post cataract surgery reviews, glaucoma monitoring and low vision services which may reduce pressure on hospital eye departments, reduce waiting times and make patient care pathways more accessible in the community.</p><p> </p><p>There is scope for further work to be done by community optometrists and the Clinical Council for eye health commissioning is working with commissioners to develop commissioning guidelines in this area.</p><p> </p><p>CCGs have the ability to develop alternatives to hospital care. We would expect patients who require further planned stages of treatment in line with their agreed care plan, to receive this treatment without undue delay and in line with when it is clinically appropriate.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL7698 HL7699 question first answered 03/05/2016 15:45:30 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

513441

	registered interest
	date	18/04/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Ophthalmology
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what plans they have to develop a national strategy for eye care.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL7698
	answer	answer is ministerial correction date of answer 03/05/2016 answer text <p>Given the size of England, and the diversity of the health needs of different communities, we believe commissioning needs to be owned and managed locally.</p><p>Therefore, there are no plans to develop a national strategy for eye care.</p><p> </p><p>Clinical commissioning groups (CCGs) are responsible for commissioning hospital eye services and for holding their providers to account in terms of contract performance. CCGs are also able to commission eye care services from community optometrists where they judge them to be needed in their areas over and above the sight tests commissioned by NHS England. Such services could include post cataract surgery reviews, glaucoma monitoring and low vision services which may reduce pressure on hospital eye departments, reduce waiting times and make patient care pathways more accessible in the community.</p><p> </p><p>There is scope for further work to be done by community optometrists and the Clinical Council for eye health commissioning is working with commissioners to develop commissioning guidelines in this area.</p><p> </p><p>CCGs have the ability to develop alternatives to hospital care. We would expect patients who require further planned stages of treatment in line with their agreed care plan, to receive this treatment without undue delay and in line with when it is clinically appropriate.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL7697 HL7699 question first answered 03/05/2016 15:45:30 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

513442

	registered interest
	date	18/04/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Ophthalmology: Waiting Lists
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of the comments by the President of the Royal College of Ophthalmologists that hundreds of patients are going blind because hospitals cannot meet the demand for appointments.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL7699
	answer	answer is ministerial correction date of answer 03/05/2016 answer text <p>Given the size of England, and the diversity of the health needs of different communities, we believe commissioning needs to be owned and managed locally.</p><p>Therefore, there are no plans to develop a national strategy for eye care.</p><p> </p><p>Clinical commissioning groups (CCGs) are responsible for commissioning hospital eye services and for holding their providers to account in terms of contract performance. CCGs are also able to commission eye care services from community optometrists where they judge them to be needed in their areas over and above the sight tests commissioned by NHS England. Such services could include post cataract surgery reviews, glaucoma monitoring and low vision services which may reduce pressure on hospital eye departments, reduce waiting times and make patient care pathways more accessible in the community.</p><p> </p><p>There is scope for further work to be done by community optometrists and the Clinical Council for eye health commissioning is working with commissioners to develop commissioning guidelines in this area.</p><p> </p><p>CCGs have the ability to develop alternatives to hospital care. We would expect patients who require further planned stages of treatment in line with their agreed care plan, to receive this treatment without undue delay and in line with when it is clinically appropriate.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL7697 HL7698 question first answered 03/05/2016 15:45:30 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

512777

	registered interest
	date	14/04/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Junior Doctors: Conditions of Employment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what mitigating actions they propose to take in the light of the equality analysis undertaken under section 149 of the Equality Act 2010 showing that certain features of the new contract for doctors in training will have an adverse impact on women who take maternity leave.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL7666
	answer	answer is ministerial correction date of answer 28/04/2016 answer text <p>The contract published on 31 March is a huge step forward for achieving fairness for all trainee doctors. For the first time junior doctors will be paid and rewarded solely on the basis of their own hard work and achievement and pay progression will be linked to level of training rather than arbitrarily to time served.</p><p> </p><p>All junior doctors should have the same terms and conditions – a level playing field – which is ultimately what employers and the British Medical Association (BMA) want and everyone deserves.</p><p> </p><p>When the Secretary of State published <em>the Equality Analysis on the new contract for doctors and dentists in training in the NHS (“Doctors”)</em> on the 31 March 2016 on the GOV.UK website he made it clear that, as a result of considering the Equality Analysis, in accordance with his duties and obligations, he had asked for a number of changes to the draft contract to address specific issues for certain groups with protected characteristics. This has been done and the contract has been duly amended. These changes included changes that benefited staff who work part time. The new contract is not discriminatory it ensures that all junior doctors receive equal pay for work of equal value. The BMA’s own lawyers have advised that nothing in the new contract is discriminatory. Nevertheless the equality duty is an ongoing duty and it is intended that monitoring will continue after the introduction of the new contract in accordance with the public sector equality duty in the Equality Act 2010.</p><p> </p><p>A copy of the Equality Analysis is attached.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL7664 HL7665 HL7667 HL7668 question first answered 28/04/2016 13:54:06 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name HL PQ 7664 Junior Doctors EIA - Final.pdf title Junior Doctors EIA
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

512775

	registered interest
	date	14/04/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Junior Doctors: Conditions of Employment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what changes they propose to make in the new contract for doctors in training in the light of the equality analysis undertaken under section 149 of the Equality Act 2010.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL7664
	answer	answer is ministerial correction date of answer 28/04/2016 answer text <p>The contract published on 31 March is a huge step forward for achieving fairness for all trainee doctors. For the first time junior doctors will be paid and rewarded solely on the basis of their own hard work and achievement and pay progression will be linked to level of training rather than arbitrarily to time served.</p><p> </p><p>All junior doctors should have the same terms and conditions – a level playing field – which is ultimately what employers and the British Medical Association (BMA) want and everyone deserves.</p><p> </p><p>When the Secretary of State published <em>the Equality Analysis on the new contract for doctors and dentists in training in the NHS (“Doctors”)</em> on the 31 March 2016 on the GOV.UK website he made it clear that, as a result of considering the Equality Analysis, in accordance with his duties and obligations, he had asked for a number of changes to the draft contract to address specific issues for certain groups with protected characteristics. This has been done and the contract has been duly amended. These changes included changes that benefited staff who work part time. The new contract is not discriminatory it ensures that all junior doctors receive equal pay for work of equal value. The BMA’s own lawyers have advised that nothing in the new contract is discriminatory. Nevertheless the equality duty is an ongoing duty and it is intended that monitoring will continue after the introduction of the new contract in accordance with the public sector equality duty in the Equality Act 2010.</p><p> </p><p>A copy of the Equality Analysis is attached.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL7665 HL7666 HL7667 HL7668 question first answered 28/04/2016 13:54:06 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name HL PQ 7664 Junior Doctors EIA - Final.pdf title Junior Doctors EIA
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

512776

	registered interest
	date	14/04/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Junior Doctors: Conditions of Employment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what mitigating actions they propose to take with regards to the new contract for doctors in training in the light of the equality analysis undertaken under section 149 of the Equality Act 2010 showing that certain features of that contract will have an adverse impact on those who work part-time, who are predominantly women.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL7665
	answer	answer is ministerial correction date of answer 28/04/2016 answer text <p>The contract published on 31 March is a huge step forward for achieving fairness for all trainee doctors. For the first time junior doctors will be paid and rewarded solely on the basis of their own hard work and achievement and pay progression will be linked to level of training rather than arbitrarily to time served.</p><p> </p><p>All junior doctors should have the same terms and conditions – a level playing field – which is ultimately what employers and the British Medical Association (BMA) want and everyone deserves.</p><p> </p><p>When the Secretary of State published <em>the Equality Analysis on the new contract for doctors and dentists in training in the NHS (“Doctors”)</em> on the 31 March 2016 on the GOV.UK website he made it clear that, as a result of considering the Equality Analysis, in accordance with his duties and obligations, he had asked for a number of changes to the draft contract to address specific issues for certain groups with protected characteristics. This has been done and the contract has been duly amended. These changes included changes that benefited staff who work part time. The new contract is not discriminatory it ensures that all junior doctors receive equal pay for work of equal value. The BMA’s own lawyers have advised that nothing in the new contract is discriminatory. Nevertheless the equality duty is an ongoing duty and it is intended that monitoring will continue after the introduction of the new contract in accordance with the public sector equality duty in the Equality Act 2010.</p><p> </p><p>A copy of the Equality Analysis is attached.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL7664 HL7666 HL7667 HL7668 question first answered 28/04/2016 13:54:06 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name HL PQ 7664 Junior Doctors EIA - Final.pdf title Junior Doctors EIA
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

512778

	registered interest
	date	14/04/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Junior Doctors: Conditions of Employment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what mitigating actions they propose to take in the light of the equality analysis undertaken under section 149 of the Equality Act 2010 showing that certain features of the new contract for doctors in training will have an adverse impact on carers, who are disproportionately women.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL7667
	answer	answer is ministerial correction date of answer 28/04/2016 answer text <p>The contract published on 31 March is a huge step forward for achieving fairness for all trainee doctors. For the first time junior doctors will be paid and rewarded solely on the basis of their own hard work and achievement and pay progression will be linked to level of training rather than arbitrarily to time served.</p><p> </p><p>All junior doctors should have the same terms and conditions – a level playing field – which is ultimately what employers and the British Medical Association (BMA) want and everyone deserves.</p><p> </p><p>When the Secretary of State published <em>the Equality Analysis on the new contract for doctors and dentists in training in the NHS (“Doctors”)</em> on the 31 March 2016 on the GOV.UK website he made it clear that, as a result of considering the Equality Analysis, in accordance with his duties and obligations, he had asked for a number of changes to the draft contract to address specific issues for certain groups with protected characteristics. This has been done and the contract has been duly amended. These changes included changes that benefited staff who work part time. The new contract is not discriminatory it ensures that all junior doctors receive equal pay for work of equal value. The BMA’s own lawyers have advised that nothing in the new contract is discriminatory. Nevertheless the equality duty is an ongoing duty and it is intended that monitoring will continue after the introduction of the new contract in accordance with the public sector equality duty in the Equality Act 2010.</p><p> </p><p>A copy of the Equality Analysis is attached.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL7664 HL7665 HL7666 HL7668 question first answered 28/04/2016 13:54:06 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name HL PQ 7664 Junior Doctors EIA - Final.pdf title Junior Doctors EIA
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

512779

	registered interest
	date	14/04/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Junior Doctors: Conditions of Employment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government whether they accept the recommendation of the report of the equality analysis undertaken under section 149 of the Equality Act 2010 that a number of steps be taken to amend the draft new contract for doctors in training to address the position of part-time doctors in order to advance equality of opportunity between men and women doctors.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL7668
	answer	answer is ministerial correction date of answer 28/04/2016 answer text <p>The contract published on 31 March is a huge step forward for achieving fairness for all trainee doctors. For the first time junior doctors will be paid and rewarded solely on the basis of their own hard work and achievement and pay progression will be linked to level of training rather than arbitrarily to time served.</p><p> </p><p>All junior doctors should have the same terms and conditions – a level playing field – which is ultimately what employers and the British Medical Association (BMA) want and everyone deserves.</p><p> </p><p>When the Secretary of State published <em>the Equality Analysis on the new contract for doctors and dentists in training in the NHS (“Doctors”)</em> on the 31 March 2016 on the GOV.UK website he made it clear that, as a result of considering the Equality Analysis, in accordance with his duties and obligations, he had asked for a number of changes to the draft contract to address specific issues for certain groups with protected characteristics. This has been done and the contract has been duly amended. These changes included changes that benefited staff who work part time. The new contract is not discriminatory it ensures that all junior doctors receive equal pay for work of equal value. The BMA’s own lawyers have advised that nothing in the new contract is discriminatory. Nevertheless the equality duty is an ongoing duty and it is intended that monitoring will continue after the introduction of the new contract in accordance with the public sector equality duty in the Equality Act 2010.</p><p> </p><p>A copy of the Equality Analysis is attached.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL7664 HL7665 HL7666 HL7667 question first answered 28/04/2016 13:54:06 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name HL PQ 7664 Junior Doctors EIA - Final.pdf title Junior Doctors EIA
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath